Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Oncology Injection Drug industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Alza
CordenPharma
Debiopharm
Eli Lilly
Praecis Pharmaceuticals
Allos Therapeutics
Merrimack
SG Biopharm
Millennium Pharmaceuticals
Ferring Pharmaceuticals
Pharmascience
Genzyme
Taj Oncology
By Type:
Circulatory/Musculoskeletal System
Central Nervous System
Organs
By Application:
Lymphoma
Myeloma
Prostate Cancer
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Oncology Injection Drug Market Overview 2018-2029
-
1.1 China Oncology Injection Drug Industry Development Overview
-
1.2 China Oncology Injection Drug Industry Development History
-
1.3 China Oncology Injection Drug Industry Market Size (2018-2029)
-
1.4 China Oncology Injection Drug Market Analysis by Type from Production Side
-
1.4.1 China Oncology Injection Drug Production Volume, Production Value and Growth Rate of Circulatory/Musculoskeletal System (2018-2029)
-
1.4.2 China Oncology Injection Drug Production Volume, Production Value and Growth Rate of Central Nervous System (2018-2029)
-
1.4.3 China Oncology Injection Drug Production Volume, Production Value and Growth Rate of Organs (2018-2029)
-
1.5 China Oncology Injection Drug Market Analysis by Application from Consumption End
-
1.5.1 China Oncology Injection Drug Sales Volume, Sales Value and Growth Rate of Lymphoma (2018-2029)
-
1.5.2 China Oncology Injection Drug Sales Volume, Sales Value and Growth Rate of Myeloma (2018-2029)
-
1.5.3 China Oncology Injection Drug Sales Volume, Sales Value and Growth Rate of Prostate Cancer (2018-2029)
-
1.6 China Oncology Injection Drug Market Analysis by Region
-
1.6.1 North China Oncology Injection Drug Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Oncology Injection Drug Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Oncology Injection Drug Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Oncology Injection Drug Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Oncology Injection Drug Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Oncology Injection Drug Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Oncology Injection Drug Market Size and Growth Rate from 2018-2029
Chapter 2 China Oncology Injection Drug Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Oncology Injection Drug Market Status and Competition at home and abroad in 2023
-
2.2.2 China Oncology Injection Drug Market Status and Competition Analysis in 2023
-
2.2.3 China Oncology Injection Drug Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Oncology Injection Drug Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Oncology Injection Drug Industry Development
Chapter 3 Oncology Injection DrugIndustry Chain Analysis
-
3.1 Oncology Injection Drug Industry Chain
-
3.2 Oncology Injection Drug Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Oncology Injection Drug Market
-
3.3 Oncology Injection Drug Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Oncology Injection Drug Market
Chapter 4 China Oncology Injection Drug Market, by Type
-
4.1 China Oncology Injection Drug Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Oncology Injection Drug Total Production Volume and Growth Rate from Production Side
-
4.5 China Oncology Injection Drug Production Volume and Growth Rate, by Type
-
4.5.1 China Oncology Injection Drug Production Volume and Growth Rate of Circulatory/Musculoskeletal System
-
4.5.2 China Oncology Injection Drug Production Volume and Growth Rate of Central Nervous System
-
4.5.3 China Oncology Injection Drug Production Volume and Growth Rate of Organs
Chapter 5 China Oncology Injection Drug Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Oncology Injection Drug Total Market Size and Growth Rate from Consumption End
-
5.5 China Oncology Injection Drug Market Size and Growth Rate, by Application
-
5.5.1 China Oncology Injection Drug Market Size and Growth Rate of Lymphoma
-
5.5.2 China Oncology Injection Drug Market Size and Growth Rate of Myeloma
-
5.5.3 China Oncology Injection Drug Market Size and Growth Rate of Prostate Cancer
Chapter 6 China Oncology Injection Drug Market, by Region
-
6.1 China Oncology Injection Drug Production Volume and Production Value, by Region
-
6.2 China Oncology Injection Drug Sales Volume and Sales Value, by Region
Chapter 7 North China Oncology Injection Drug Market Analysis
-
7.1 North China Oncology Injection Drug Market, by Type
-
7.2 North China Oncology Injection Drug Market, by Application
Chapter 8 Central China Oncology Injection Drug Market Analysis
-
8.1 Central China Oncology Injection Drug Market, by Type
-
8.2 Central China Oncology Injection Drug Market, by Application
Chapter 9 South China Oncology Injection Drug Market Analysis
-
9.1 South China Oncology Injection Drug Market, by Type
-
9.2 South China Oncology Injection Drug Market, by Application
Chapter 10 East China Oncology Injection Drug Market Analysis
-
10.1 East China Oncology Injection Drug Market, by Type
-
10.2 East China Oncology Injection Drug Market, by Application
Chapter 11 Northeast China Oncology Injection Drug Market Analysis
-
11.1 Northeast China Oncology Injection Drug Market, by Type
-
11.2 Northeast China Oncology Injection Drug Market, by Application
Chapter 12 Southwest China Oncology Injection Drug Market Analysis
-
12.1 Southwest China Oncology Injection Drug Market, by Type
-
12.2 Southwest China Oncology Injection Drug Market, by Application
Chapter 13 Northwest China Oncology Injection Drug Market Analysis
-
13.1 Northwest China Oncology Injection Drug Market, by Type
-
13.2 Northwest China Oncology Injection Drug Market, by Application
Chapter 14 Company Profiles
-
14.1 Alza
-
14.1.1 Alza Company Profile
-
14.1.2 Alza Oncology Injection Drug Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 CordenPharma
-
14.2.1 CordenPharma Company Profile
-
14.2.2 CordenPharma Oncology Injection Drug Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Debiopharm
-
14.3.1 Debiopharm Company Profile
-
14.3.2 Debiopharm Oncology Injection Drug Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Eli Lilly
-
14.4.1 Eli Lilly Company Profile
-
14.4.2 Eli Lilly Oncology Injection Drug Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Praecis Pharmaceuticals
-
14.5.1 Praecis Pharmaceuticals Company Profile
-
14.5.2 Praecis Pharmaceuticals Oncology Injection Drug Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Allos Therapeutics
-
14.6.1 Allos Therapeutics Company Profile
-
14.6.2 Allos Therapeutics Oncology Injection Drug Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Merrimack
-
14.7.1 Merrimack Company Profile
-
14.7.2 Merrimack Oncology Injection Drug Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 SG Biopharm
-
14.8.1 SG Biopharm Company Profile
-
14.8.2 SG Biopharm Oncology Injection Drug Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Millennium Pharmaceuticals
-
14.9.1 Millennium Pharmaceuticals Company Profile
-
14.9.2 Millennium Pharmaceuticals Oncology Injection Drug Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Ferring Pharmaceuticals
-
14.10.1 Ferring Pharmaceuticals Company Profile
-
14.10.2 Ferring Pharmaceuticals Oncology Injection Drug Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 Pharmascience
-
14.11.1 Pharmascience Company Profile
-
14.11.2 Pharmascience Oncology Injection Drug Market Performance
-
14.11.3 Product&Service Introduction
-
14.12 Genzyme
-
14.12.1 Genzyme Company Profile
-
14.12.2 Genzyme Oncology Injection Drug Market Performance
-
14.12.3 Product&Service Introduction
-
14.13 Taj Oncology
-
14.13.1 Taj Oncology Company Profile
-
14.13.2 Taj Oncology Oncology Injection Drug Market Performance
-
14.13.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Oncology Injection Drug Industry Research Conclusions
-
15.2 Oncology Injection Drug Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Oncology Injection Drug Industry Market Size (2018-2029)
-
Figure China Oncology Injection Drug Production Volume, Production Value and Growth Rate of Circulatory/Musculoskeletal System (2018-2029)
-
Figure China Oncology Injection Drug Production Volume, Production Value and Growth Rate of Central Nervous System (2018-2029)
-
Figure China Oncology Injection Drug Production Volume, Production Value and Growth Rate of Organs (2018-2029)
-
Figure China Oncology Injection Drug Sales Volume, Sales Value and Growth Rate of Lymphoma (2018-2029)
-
Figure China Oncology Injection Drug Sales Volume, Sales Value and Growth Rate of Myeloma (2018-2029)
-
Figure China Oncology Injection Drug Sales Volume, Sales Value and Growth Rate of Prostate Cancer (2018-2029)
-
Figure North China Oncology Injection Drug Market Size and Growth Rate from 2018-2029
-
Figure Central China Oncology Injection Drug Market Size and Growth Rate from 2018-2029
-
Figure South China Oncology Injection Drug Market Size and Growth Rate from 2018-2029
-
Figure East China Oncology Injection Drug Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Oncology Injection Drug Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Oncology Injection Drug Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Oncology Injection Drug Market Size and Growth Rate from 2018-2029
-
Figure Oncology Injection Drug Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Oncology Injection Drug Market Share by Type in 2018
-
Figure China Oncology Injection Drug Market Share by Type in 2023
-
Figure China Oncology Injection Drug Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Oncology Injection Drug Production Volume and Growth Rate of Circulatory/Musculoskeletal System (2018-2023)
-
Figure China Oncology Injection Drug Production Volume and Growth Rate of Central Nervous System (2018-2023)
-
Figure China Oncology Injection Drug Production Volume and Growth Rate of Organs (2018-2023)
-
Figure China Oncology Injection Drug Market Share by Application in 2018
-
Figure China Oncology Injection Drug Market Share by Application in 2023
-
Figure China Oncology Injection Drug Total Market Size and Growth Rate from Consumption End
-
Figure China Oncology Injection Drug Market Size and Growth Rate of Lymphoma (2018-2023)
-
Figure China Oncology Injection Drug Market Size and Growth Rate of Myeloma (2018-2023)
-
Figure China Oncology Injection Drug Market Size and Growth Rate of Prostate Cancer (2018-2023)
-
Table China Oncology Injection Drug Production Volume by Region (2018-2023)
-
Table China Oncology Injection Drug Production Volume Share by Region (2018-2023)
-
Figure China Oncology Injection Drug Production Volume Share by Region (2018-2023)
-
Table China Oncology Injection Drug Production Value by Region (2018-2023)
-
Table China Oncology Injection Drug Production Value Share by Region (2018-2023)
-
Figure China Oncology Injection Drug Production Value Share by Region (2018-2023)
-
Table China Oncology Injection Drug Sales Volume by Region (2018-2023)
-
Table China Oncology Injection Drug Sales Volume Share by Region (2018-2023)
-
Figure China Oncology Injection Drug Sales Volume Share by Region (2018-2023)
-
Table China Oncology Injection Drug Sales Value by Region (2018-2023)
-
Table China Oncology Injection Drug Sales Value Share by Region (2018-2023)
-
Figure China Oncology Injection Drug Sales Value Share by Region (2018-2023)
-
Table North China Oncology Injection Drug Production Volume by Type (2018-2023)
-
Table North China Oncology Injection Drug Production Volume Share by Type (2018-2023)
-
Figure North China Oncology Injection Drug Production Volume Share by Type (2018-2023)
-
Table North China Oncology Injection Drug Sales Volume by Application (2018-2023)
-
Table North China Oncology Injection Drug Sales Volume Share by Application (2018-2023)
-
Figure North China Oncology Injection Drug Sales Volume Share by Application (2018-2023)
-
Table Central China Oncology Injection Drug Production Volume by Type (2018-2023)
-
Table Central China Oncology Injection Drug Production Volume Share by Type (2018-2023)
-
Figure Central China Oncology Injection Drug Production Volume Share by Type (2018-2023)
-
Table Central China Oncology Injection Drug Sales Volume by Application (2018-2023)
-
Table Central China Oncology Injection Drug Sales Volume Share by Application (2018-2023)
-
Figure Central China Oncology Injection Drug Sales Volume Share by Application (2018-2023)
-
Table South China Oncology Injection Drug Production Volume by Type (2018-2023)
-
Table South China Oncology Injection Drug Production Volume Share by Type (2018-2023)
-
Figure South China Oncology Injection Drug Production Volume Share by Type (2018-2023)
-
Table South China Oncology Injection Drug Sales Volume by Application (2018-2023)
-
Table South China Oncology Injection Drug Sales Volume Share by Application (2018-2023)
-
Figure South China Oncology Injection Drug Sales Volume Share by Application (2018-2023)
-
Table East China Oncology Injection Drug Production Volume by Type (2018-2023)
-
Table East China Oncology Injection Drug Production Volume Share by Type (2018-2023)
-
Figure East China Oncology Injection Drug Production Volume Share by Type (2018-2023)
-
Table East China Oncology Injection Drug Sales Volume by Application (2018-2023)
-
Table East China Oncology Injection Drug Sales Volume Share by Application (2018-2023)
-
Figure East China Oncology Injection Drug Sales Volume Share by Application (2018-2023)
-
Table Northeast China Oncology Injection Drug Production Volume by Type (2018-2023)
-
Table Northeast China Oncology Injection Drug Production Volume Share by Type (2018-2023)
-
Figure Northeast China Oncology Injection Drug Production Volume Share by Type (2018-2023)
-
Table Northeast China Oncology Injection Drug Sales Volume by Application (2018-2023)
-
Table Northeast China Oncology Injection Drug Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Oncology Injection Drug Sales Volume Share by Application (2018-2023)
-
Table Southwest China Oncology Injection Drug Production Volume by Type (2018-2023)
-
Table Southwest China Oncology Injection Drug Production Volume Share by Type (2018-2023)
-
Figure Southwest China Oncology Injection Drug Production Volume Share by Type (2018-2023)
-
Table Southwest China Oncology Injection Drug Sales Volume by Application (2018-2023)
-
Table Southwest China Oncology Injection Drug Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Oncology Injection Drug Sales Volume Share by Application (2018-2023)
-
Table Northwest China Oncology Injection Drug Production Volume by Type (2018-2023)
-
Table Northwest China Oncology Injection Drug Production Volume Share by Type (2018-2023)
-
Figure Northwest China Oncology Injection Drug Production Volume Share by Type (2018-2023)
-
Table Northwest China Oncology Injection Drug Sales Volume by Application (2018-2023)
-
Table Northwest China Oncology Injection Drug Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Oncology Injection Drug Sales Volume Share by Application (2018-2023)
-
Table Alza Company Profile
-
Table Alza Oncology Injection Drug Revenue, Price and Gross (2018-2023)
-
Table CordenPharma Company Profile
-
Table CordenPharma Oncology Injection Drug Revenue, Price and Gross (2018-2023)
-
Table Debiopharm Company Profile
-
Table Debiopharm Oncology Injection Drug Revenue, Price and Gross (2018-2023)
-
Table Eli Lilly Company Profile
-
Table Eli Lilly Oncology Injection Drug Revenue, Price and Gross (2018-2023)
-
Table Praecis Pharmaceuticals Company Profile
-
Table Praecis Pharmaceuticals Oncology Injection Drug Revenue, Price and Gross (2018-2023)
-
Table Allos Therapeutics Company Profile
-
Table Allos Therapeutics Oncology Injection Drug Revenue, Price and Gross (2018-2023)
-
Table Merrimack Company Profile
-
Table Merrimack Oncology Injection Drug Revenue, Price and Gross (2018-2023)
-
Table SG Biopharm Company Profile
-
Table SG Biopharm Oncology Injection Drug Revenue, Price and Gross (2018-2023)
-
Table Millennium Pharmaceuticals Company Profile
-
Table Millennium Pharmaceuticals Oncology Injection Drug Revenue, Price and Gross (2018-2023)
-
Table Ferring Pharmaceuticals Company Profile
-
Table Ferring Pharmaceuticals Oncology Injection Drug Revenue, Price and Gross (2018-2023)
-
Table Pharmascience Company Profile
-
Table Pharmascience Oncology Injection Drug Revenue, Price and Gross (2018-2023)
-
Table Genzyme Company Profile
-
Table Genzyme Oncology Injection Drug Revenue, Price and Gross (2018-2023)
-
Table Taj Oncology Company Profile
-
Table Taj Oncology Oncology Injection Drug Revenue, Price and Gross (2018-2023)
-
